MB

Mark Bodmer

CL Celltech Therapeutics Limited: 6 patents #11 of 55Top 20%
CC Celltech Co.: 3 patents #6 of 65Top 10%
CL Celltech R&D Limited: 2 patents #35 of 99Top 40%
EB Evelo Biosciences: 1 patents #20 of 25Top 80%
Hoechst Gmbh: 1 patents #2,248 of 4,020Top 60%
SS Solvay Sa: 1 patents #185 of 433Top 45%
Overall (All Time): #343,314 of 4,157,543Top 9%
14
Patents All Time

Issued Patents All Time

Patent #TitleCo-InventorsDate
11266700 Compositions and methods for treating immune disorders using immune modulating Lactococcus bacteria strains Brian Goodman, Holly Ponichtera, Andrea Itano, Taylor A. Cormack, Maria Sizova +3 more 2022-03-08
RE39548 Interleukin-5 specific recombinant antibodies Diljeet Singh Athwal, John Spencer Emtage 2007-04-03
6734286 Interleukin-5 specific recombinant antibodies Diljeet Singh Athwal, John Spencer Emtage 2004-05-11
6316227 Nucleic acids encoding interleukin-5 specific recombinant antibodies Diljeet Singh Athwal, John Spencer Emtage 2001-11-13
6315999 Pharmaceutical product for the treatment of sepsis Jerald C. Sadoff, Steven M. Opal, Alan Cross 2001-11-13
6180377 Humanized antibodies Susan Adrienne Morgan, John Spencer Emtage, Diljeet Singh Athwal 2001-01-30
6013642 Use of estrone derivatives as steroid sulphatase inhibitors Roland Foulkes, John Spencer Emtage, Martin Rae Wales, Graham A. W. Rook 2000-01-11
5998586 Interleukin-5 specific recombinant antibodies Diljeet Singh Athwal, John Spencer Emtage 1999-12-07
5994510 Recombinant antibodies specific for TNF.alpha. John Robert Adair, Diljeet Singh Athwal, John Spencer Emtage 1999-11-30
5965405 Method for producing Fv fragments in eukaryotic cells Gregory Paul Winter, Lutz Riechmann, Geoffrey T. Yarranton, Raymond John Owens 1999-10-12
5958413 Use of antibodies to TNF or fragments derived thereof and xanthine derivatives for combination therapy and compositions therefor Hiristo Anagnostopulos, Ulrich Gebert, Heinz Hanel, Michael Limbert, Gerald Anthony Higgs 1999-09-28
5877293 CDR grafted anti-CEA antibodies and their production John Robert Adair, Andrew Mountain, Raymond John Owens 1999-03-02
5677425 Recombinant antibody John Robert Adair, Nigel Richard Whittle 1997-10-14
5219996 Recombinant antibodies and methods for their production in which surface residues are altered to cysteine residues for attachment of effector or receptor molecules John Robert Adair, Nigel Richard Whittle, Alan Howard Lyons, Raymond John Owens 1993-06-15